Nat Immunol:吃饭也会“发炎”?到底咋回事!

2017-01-20 佚名 生物谷

我们吃东西不仅摄取了营养,也会吃进一定数量的细菌。机体在摄取消化产生的葡萄糖的同时还需要与大量细菌斗争,这就会触发炎症性应答从而激活健康人的免疫系统提供保护作用。来自巴塞尔大学医院的研究人员首次证明了这一现象,他们还发现对于超重的人来说,这种炎症性应答不能显著发生进而导致糖尿病。 众所周知2型糖尿病会伴随着慢性炎症产生的许多负面影响。因此大量临床研究都通过限制IL-1β这种炎症分子的


我们吃东西不仅摄取了营养,也会吃进一定数量的细菌。机体在摄取消化产生的葡萄糖的同时还需要与大量细菌斗争,这就会触发炎症性应答从而激活健康人的免疫系统提供保护作用。来自巴塞尔大学医院的研究人员首次证明了这一现象,他们还发现对于超重的人来说,这种炎症性应答不能显著发生进而导致糖尿病

众所周知2型糖尿病会伴随着慢性炎症产生的许多负面影响。因此大量临床研究都通过限制IL-1β这种炎症分子的过度合成来治疗糖尿病。对于糖尿病患者来说,这种炎症分子能够触发慢性炎症引起负责胰岛素合成的β细胞衰竭。

免疫系统激活

但是炎症也会起到一些积极作用,巴塞尔大学医院的研究人员在国际学术期刊Nature Immunology上发表的这项新研究表明对于健康人来说,短期的炎症应答在糖摄取和免疫系统激活方面发挥着重要作用。

在他们的工作中,研究人员证明小肠周围巨噬细胞的数量会在进食的时候出现增加。这些巨噬细胞能够根据葡萄糖水平进行IL-1β的合成,IL-1β可以进而刺激胰腺β细胞合成胰岛素。缺少内源性IL-1β信号的小鼠在再进食和肥胖的情况下会出现血浆胰岛素水平降低的情况。 IL-1β和胰岛素可以增加巨噬细胞对葡萄糖的摄取,确保免疫系统得到充足的葡萄糖供应从而保持活跃。

细菌和营养

据研究人员介绍,这种代谢和免疫机制依赖于摄入的细菌和消化的营养物质。当营养物质充足免疫系统就能够充分发挥对抗外来细菌的作用。与之相反,当缺乏营养物质,机体剩余的能量必须用于更加重要的生命功能。这可能也部分解释了为什么饥饿的时候会更容易患上传染性疾病。

原始出处

Erez Dror, Elise Dalmas, Daniel T Meier, Stephan Wueest.et.al.Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation.Nat Immunol.2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1881632, encodeId=6cc518816329d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 02 03:45:00 CST 2017, time=2017-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171593, encodeId=c6b81e1593dc, content=免疫反应还有很多值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TMKicgf58mJaQxKhBsHa2jnPrEYVBnZ8QD4tbiaUo3aNqM7EUfOzoPiaEELUb7VRE0HKA/132, createdBy=afcb2012691, createdName=1e1f3a67m99(暂无匿称), createdTime=Fri Jan 20 14:22:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171583, encodeId=1afb1e1583aa, content=签到学习了~~……, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Fri Jan 20 11:41:45 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171550, encodeId=bf461e155027, content=文章太好了,多读受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Jan 20 10:17:50 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-04-02 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1881632, encodeId=6cc518816329d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 02 03:45:00 CST 2017, time=2017-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171593, encodeId=c6b81e1593dc, content=免疫反应还有很多值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TMKicgf58mJaQxKhBsHa2jnPrEYVBnZ8QD4tbiaUo3aNqM7EUfOzoPiaEELUb7VRE0HKA/132, createdBy=afcb2012691, createdName=1e1f3a67m99(暂无匿称), createdTime=Fri Jan 20 14:22:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171583, encodeId=1afb1e1583aa, content=签到学习了~~……, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Fri Jan 20 11:41:45 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171550, encodeId=bf461e155027, content=文章太好了,多读受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Jan 20 10:17:50 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 1e1f3a67m99(暂无匿称)

    免疫反应还有很多值得研究

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1881632, encodeId=6cc518816329d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 02 03:45:00 CST 2017, time=2017-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171593, encodeId=c6b81e1593dc, content=免疫反应还有很多值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TMKicgf58mJaQxKhBsHa2jnPrEYVBnZ8QD4tbiaUo3aNqM7EUfOzoPiaEELUb7VRE0HKA/132, createdBy=afcb2012691, createdName=1e1f3a67m99(暂无匿称), createdTime=Fri Jan 20 14:22:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171583, encodeId=1afb1e1583aa, content=签到学习了~~……, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Fri Jan 20 11:41:45 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171550, encodeId=bf461e155027, content=文章太好了,多读受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Jan 20 10:17:50 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 杨柳青青

    签到学习了~~……

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1881632, encodeId=6cc518816329d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 02 03:45:00 CST 2017, time=2017-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171593, encodeId=c6b81e1593dc, content=免疫反应还有很多值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TMKicgf58mJaQxKhBsHa2jnPrEYVBnZ8QD4tbiaUo3aNqM7EUfOzoPiaEELUb7VRE0HKA/132, createdBy=afcb2012691, createdName=1e1f3a67m99(暂无匿称), createdTime=Fri Jan 20 14:22:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171583, encodeId=1afb1e1583aa, content=签到学习了~~……, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Fri Jan 20 11:41:45 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171550, encodeId=bf461e155027, content=文章太好了,多读受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Jan 20 10:17:50 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 1e10c84am36(暂无匿称)

    文章太好了,多读受益

    0